Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$9.08 USD
+0.21 (2.37%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $9.06 -0.02 (-0.22%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.08 USD
+0.21 (2.37%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $9.06 -0.02 (-0.22%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
Zacks News
Cardinal Health Banks on Buyouts Amid Intense Competition
by Zacks Equity Research
Cardinal Health (CAH) consistently works on launching products and carrying out acquisitions to boost revenues.
Bear of the Day: Revlon (REV)
by Madeleine Johnson
This cosmetics giant may not be the best beauty fix for your portfolio right now.
AmerisourceBergen (ABC) Beats Q4 Earnings, Issues FY18 View
by Zacks Equity Research
Solid growth in the Pharmaceutical Distribution Services segment drove AmerisourceBergen's (ABC) top line in the fourth quarter.
Bear of the Day: GNC Holdings (GNC)
by Ryan McQueeney
The decline of brick-and-mortar stores has been well-documented, but this specialty retailer has problems all its own.
Top Research Reports for JPMorgan Chase, Gilead & ConocoPhillips
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase (JPM), Gilead (GILD) and ConocoPhillips (COP).
Astounding Earnings Overall
by Zacks Equity Research
Astounding Earnings Overall
Walgreens Boots (WBA) Tops Q4 Earnings, Revenues Estimates
by Zacks Equity Research
Walgreens Boots (WBA) rides high in Q4 on strength in Retail Pharmacy USA division and Pharmaceutical Wholesale division.
Rite Aid Stock Down 80% This Year: Is Amazon the Only Threat?
by Zacks Equity Research
Amazon's expansion strategy is not the only reason behind Rite Aid's (RAD) debacle. Let's take a look at the other reasons for which this stock has lost ground.
Top Analyst Reports for Citigroup, 3M & Walgreens Boots
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Citigroup (C), 3M (MMM) and Walgreens Boots (WBA).
Why Did Rite Aid (RAD) Stock Crash Today?
by Ryan McQueeney
Shares of Rite Aid (RAD) fell more than 10% on Tuesday after Walgreens Boots (WBA) received government approval to buy fewer Rite Aid stores than had initially been proposed.
Should Value Investors Consider Walgreens Boots (WBA) Stock?
by Zacks Equity Research
Is Walgreens Boots (WBA) a great pick from the value investor's perspective right now? Read on to know more.
Tobacco Stocks in Focus as Cigarette Prices Rise in New York
by Zacks Equity Research
The news of cigarette price hike in New York City and other legislations to reduce the number of smokers have raised concerns of accelerated sales declines for traditional cigarettes.
Why Is Walgreens Boots (WBA) Down 4.4% Since the Last Earnings Report?
by Zacks Equity Research
Walgreens Boots (WBA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Walgreens, Rite Aid Ditch Long-Suffering Drugstore Merger
by Madeleine Johnson
On Thursday, Walgreens Boots Alliance (WBA) announced that it has abandoned efforts to merge with fellow drugstore chain Rite Aid (RAD). Instead, Walgreens will purchase almost half if its rivals stores in a new deal.
Walgreens Boots (WBA) Tops Q3 Earnings, Revenues Estimates
by Zacks Equity Research
Currently, Walgreens Boots has a Zacks Rank #3 (Hold) but that could change following its impressive third quarter fiscal 2017 earnings report which has just released.
Top Analyst Reports for Amazon, Visa, Verizon & Citigroup
by Mark Vickery
Today's Research Daily features new research reports on 17 major stocks, including Amazon (AMZN), Visa (V), Verizon (VZ) and Citigroup (C).
Is Walgreens (WBA) a Great Stock for Value Investors?
by Zacks Equity Research
Value investing is easily one of the most popular ways to find great stocks in any market environment.
Could Amazon Be the Next Big Pharmacy Giant?
by Madeleine Johnson
Amazon is reportedly looking to expand into new territory. According to CNBC, the e-commerce giant is trying to figure out how it can break into the multi-billion-dollar pharmacy industry.
Walgreens Boots (WBA) Up 5.4% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Walgreens Boots (WBA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Research Reports for Today: AMZN, CELG, FB, WBA
by Mark Vickery
Today's Research Daily features new research reports on 17 major stocks, including Amazon (AMZN), Celgene (CELG), Facebook (FB) and Walgreens Boots (WBA).
Company News for April 06, 2017
by Zacks Equity Research
Companies in the News are: PNRA,SPLS,MON,WBA
Walgreens Boots (WBA) Meets Q2 Earnings, Misses on Revenues
by Zacks Equity Research
Currently, Walgreens Boots has a Zacks Rank #3 (Hold) but that could change following its dull second quarter fiscal 2017 earnings report which has just released.
Earnings Season in Focus
by Zacks Equity Research
Earnings Season in Focus
Plenty to Look Forward To
by Mark Vickery
We are anticipating another strong quarter of growth as Q1 earnings season starts in the next couple weeks.
Handicapping the Q1 Earnings Season
by Sheraz Mian
The Q1 earnings season has gotten underway with earnings reports from 17 S&P 500 members.